Bristol-Myers Squibb partner Ono Pharmaceutical bagged a third approval in Japan for immuno-oncology drug Opdivo, its most important new product.

"Binding" $1 billion offers are said to be on the table as Indian drugmakers Aurobindo and Intas go head-to-head for Teva's generics business in…

Amid a tidal wave of backlash from politicians, media, consumers and others over its prices for EpiPen, Mylan Monday announced it would roll out a generic copy…

While they're waiting for key outcomes data on their PCSK9 cholesterol-fighters, Amgen, Sanofi and Regeneron are rolling out other studies to help bolster…

Stada’s annual meeting--the culmination of a months-long battle with a rebel investor--has come and gone, and both sides are touting a victory.

Mylan’s EpiPen tornado is far from its first storm of controversy. The top brass has caught fire for personal use of company aircraft, an unearned degree,…

After a week scrabbling to calm the EpiPen pricing crisis, Mylan has unveiled its latest tactic. The drugmaker plans to launch an authorized generic priced at…

The Attorney General of New Hampshire is accusing Purdue Pharma of dragging its feet in his investigation into Purdue’s marketing of its highly addictive…